The 340B spread mechanism permits covered entities to retain the difference between discounted acquisition cost and commercial or Medicare reimbursement, incentivizing revenue capture rather than ...
CMS intends a significant drop in reimbursement for 340B drug payment program participants, along with potentially burdensome reporting requirements for non-participants. This article was originally ...
AHA provides feedback on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act) ...
On July 10, the Centers for Medicare & Medicaid Services (CMS) released the 2025 Medicare Physician Fee Schedule (MPFS) proposed rule, which includes proposals related to identification of Medicare ...
“When a program designed to deliver targeted assistance drives up system-wide costs, reform is no longer optional,” says health expert Sally Pipes. “It's necessary.” If a charity organization ...
The CMS proposed a rule on Thursday that would slash Medicare payment rates for a program that hospitals use to buy discounted drugs and implement site-neutral payments for some imaging services next ...
On July 31, 2026, the Health Resources and Services Administration (HRSA) issued a 340B Rebate Model Pilot Program notice, setting forth an alternative to the historic upfront 340B discount model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results